Matt Jeneroux, Shadow Minister for Health, today launched online consultations to gather feedback from Canadians on the government’s Patented Medicine Prices Review Board (PMPRB) regulatory changes.

After months of Conservatives advocating on behalf of Canadians, the Trudeau government has delayed their July 1st regulatory changes until January 1, 2021.  These changes set aggressive price ceilings for some new therapies, especially those involving rare disorders, making it almost guaranteed that these new therapies will not be brought to the Canadian market.